Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 10, 2024

Efficacy of Maintenance Pembrolizumab Therapy in Patients With HER2− MBC With Prior Response to Chemotherapy

Clinical Cancer Research


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Cancer Research
Maintenance pembrolizumab therapy in patients with metastatic HER2-negative breast cancer with prior response to chemotherapy
Clin. Cancer Res 2024 Apr 17;[EPub Ahead of Print], T Iwase, EN Cohen, H Gao, A Alexander, M Kai, V Chiv, X Wang, S Krishnamurthy, D Liu, Y Shen, K Kida, A Reuben, R Layman, D Ramirez, D Tripathy, SL Moulder, C Yam, V Valero, B Lim, JM Reuben, NT Ueno

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading